Si-Bone

San Jose, United States Founded: 2008 • Age: 18 yrs
Minimally invasive titanium implants for sacroiliac joint disorders are developed.
Annual revenue $167.2M Latest available
Total funding $102.5M 7 rounds
Employees 344 Tracked headcount
Investors 8 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Si-Bone

Si-Bone is a company based in San Jose (United States) founded in 2008. Si-Bone has raised $102.52 million across 7 funding rounds from investors including SVB, Orbimed and Oxford Finance. The company has 344 employees as of December 31, 2023. Si-Bone offers products and services including iFuse Implant System, iFuse 3D, and iFuse TORQ. Si-Bone operates in a competitive market with competitors including Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.

  • Headquarter San Jose, United States
  • Employees 344 as on 31 Dec, 2023
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Si-Bone, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $167.18 M (USD)
    28
    as on Dec 31, 2024
  • Net Profit
    $1.9 M (USD)
    104
    as on Dec 31, 2024
  • EBITDA
    -$35.25 M (USD)
    25
    as on Dec 31, 2024
  • Total Equity Funding
    $102.52 M (USD)

    in 7 rounds

  • Latest Funding Round
    $20 M (USD), Series D

    Jun 17, 2016

  • Investors
    SVB

    & 7 more

  • Employee Count
    344

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Si-Bone

Si-Bone is a publicly listed company on the NASDAQ with ticker symbol SIBN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: SIBN · Sector: Health technology · USA

Products & Services of Si-Bone

Si-Bone offers a comprehensive portfolio of products and services, including iFuse Implant System, iFuse 3D, and iFuse TORQ.

Product name locked
Category locked
Primary

Device for stabilizing and fusing the sacroiliac joint

Product name locked
Category locked
Locked

Advanced implant for SI joint dysfunction treatment

Product name locked
Category locked
Locked

Implant system for pelvic trauma and fixation

People of Si-Bone

Headcount 200-500
Employee Profiles 16
Board Members and Advisors 8
Employee Profiles
People
Laura A. Francis
CEO
People
Carlton Reckling
Chief Medical Officer & VP, Medical Affairs
People
Michael Pisetsky
Chief Business & Legal Affairs Officer
People
Nikolas Kerr
SVP, Product, Strategy & Business Development

Unlock access to complete

Board Members and Advisors
people
Timothy E. Davis, Jr.
Director
people
John G. Freund
Director
people
Jeffrey Dunn
Executive Chairman
people
Gregory K. Hinckley
Director

Unlock access to complete

Funding Insights of Si-Bone

Si-Bone has successfully raised a total of $102.52M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Si-Bone

Si-Bone has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Orbimed and Oxford Finance.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare venture capital investments are made by Arboretum Ventures.
Locked Locked Locked
Venture debt firm focused on the life sciences sector
Locked Locked Locked
Growth-stage tech investments are made in North America, Europe, Israel.
Locked Locked Locked
Premium access

Investor details for Si-Bone

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Si-Bone

Investments
Premium access

Investment portfolio details for Si-Bone

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Si-Bone

Premium access

Detailed financials for Si-Bone

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Si-Bone Comparisons

Si-Bone Primary company
Description
Minimally invasive titanium implants for sacroiliac joint di...
Location
San Jose, United States
Founded Year
2008
Annual Revenue
$167.18 M (USD)
Net Profit
$1.9 M (USD)
EBITDA
-$35.25 M (USD)
Employees
344
As of 2023
Premium access

Peer comparison for Si-Bone

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Si-Bone

Si-Bone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of high-frequency spinal cord stimulation implants
Locked Locked Locked
Treatment solutions for spine disorders are developed.
Locked Locked Locked
Minimally invasive treatments for lumbar spinal stenosis are developed.
Locked Locked Locked
Stabilization devices for healthcare are manufactured by the company.
Locked Locked Locked
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain
Premium access

Detailed competitors of Si-Bone

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Si-Bone

Premium access

Complete news archive for Si-Bone

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Si-Bone

Si-Bone was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Si-Bone is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Si-Bone is a funded company, having raised a total of $102.52M across 7 funding rounds to date.

As of Dec 31, 2023, the latest employee count at Si-Bone is 344.

Annual revenue of Si-Bone is $167.18M as on Dec 31, 2024.

SI-BONE was founded in 2008 in San Jose, United States, and is engaged in the medical device sector for orthopedic treatments. The iFuse Implant System is provided as a titanium-based solution for minimally invasive sacroiliac joint fusion surgeries. A directory of physicians qualified to perform these procedures is maintained. Operations center on addressing SI joint disorders through innovative fixation technologies.

Si-Bone's top competitors include Nevro, Paradigm Spine and ATEC Spine.

Si-Bone offers iFuse Implant System, iFuse 3D, and iFuse TORQ.

Yes, Si-Bone is publicly traded on NASDAQ under the ticker symbol SIBN.

Si-Bone has 8 investors. Key investors include SVB, Orbimed, Oxford Finance, Arboretum Ventures, and Redline Capital Management.

The ticker symbol of Si-Bone is SIBN on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available